| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997012039A2 Sh2-containing inositol-phosphatase |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997012036A2 Bone stimulating factor |
| 04/03/1997 | WO1997011970A1 Cytostatin ii |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011714A1 Chemokine inhibitor |
| 04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | WO1997011712A1 Ribosome fraction and composition containing same |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2232706A1 Chemokine inhibitor |
| 04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/02/1997 | EP0765940A1 Catalytic antibody which hydrolyzes amino acid ester derivative enantioselectively |
| 04/02/1997 | EP0765937A1 Method of producing fusion proteins |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765667A1 Ribosomal fraction and composition containing it |
| 04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
| 04/02/1997 | EP0765395A1 N-terminally extended proteins expressed in yeast |
| 04/02/1997 | EP0765393A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765391A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 04/02/1997 | EP0765344A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/02/1997 | EP0765168A1 Compositions and methods for the treatment of tumors |
| 04/02/1997 | EP0654085B1 Monomeric and dimeric antibody-fragment fusion proteins |
| 04/02/1997 | EP0535048B1 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments |
| 04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
| 04/02/1997 | EP0436597B1 Generation and selection of recombinant varied binding proteins |
| 04/02/1997 | CN1146730A 抗体纯化 Antibody Purification |
| 04/02/1997 | CN1146724A Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 04/02/1997 | CN1034428C Expression and secretion heterogenous protein with yarrowia lipolytica yeast transformant |
| 04/02/1997 | CN1034427C Method of producing peptides, recombinant plasmid for use in same and animal cells transformed with same |
| 04/01/1997 | US5616685 snRNP-A antigen and fragments thereof |
| 04/01/1997 | US5616595 Concentration, solubilizing, diafiltration in a closed recirculation system |
| 04/01/1997 | US5616559 Genetic engineered polypeptide viricides inhibiting virus transcription and replication |
| 04/01/1997 | US5616555 Crystalline r-h-GM-CSF and method |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
| 04/01/1997 | US5616481 Genetic engineered dna technology in neurobiology |
| 04/01/1997 | US5616478 Providing immobilized medium including aqueous liquid phase containing cell-free enzymatic amplification system entrapped in solid water insoluble matrix, distributing nucleic acid molecule templates therein, incubating |
| 04/01/1997 | US5616476 Synthetic isohirudins with improved stability |
| 04/01/1997 | US5616474 K. lactis transaldolase gene promoter and use thereof |
| 04/01/1997 | US5616472 Process for producing monoclonal antibodies against human T cell receptor elements using recombinant DNA vectors, and cells transfected thereby |
| 04/01/1997 | US5616468 Compositions and diagnostic methods using monoclonal antibodies against CD44v6 |
| 04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 04/01/1997 | CA1339044C Insulin derivatives, the use thereof, and a pharmaceutical composition containing them |
| 04/01/1997 | CA1339033C Glycopeptide antibiotics a82846 from nocardia orientalis |
| 04/01/1997 | CA1339032C Forms of colony stimulating factor-1 |
| 03/27/1997 | WO1997011370A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | WO1997011192A1 Dna encoding medicinal proteins |
| 03/27/1997 | WO1997011186A1 Process for producing natriuretic peptides via streptavidine fusion proteins |
| 03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011094A1 Novel variants of green fluorescent protein, gfp |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 03/27/1997 | WO1997005253A3 Transketolase-related protein |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | DE19535445A1 Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine A process for producing natriuretic peptides via streptavidin-fusion proteins |
| 03/27/1997 | DE19535321A1 Neues Adhäsin aus Helicobacter pylori Create an adhesin of Helicobacter pylori |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232841A1 Process for producing natriuretic peptides via streptavidine fusion proteins |
| 03/27/1997 | CA2232730A1 New adhesin from helicobacter pylori |
| 03/27/1997 | CA2232601A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2232193A1 Dna encoding medicinal proteins |
| 03/26/1997 | EP0764722A2 DNA encoding primate leptins as medicinal proteins |
| 03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
| 03/26/1997 | EP0764719A2 Methods for animal cell culture |
| 03/26/1997 | EP0764657A1 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 03/26/1997 | EP0764209A1 Yeast strains |
| 03/26/1997 | EP0764208A1 Bmp-9 compositions |
| 03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
| 03/26/1997 | EP0764202A1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 03/26/1997 | EP0764172A1 Synthetic peptide analogs of lung surfactant protein sp-c |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 03/26/1997 | EP0763982A1 Novel bioemulsifiers |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/25/1997 | US5614619 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
| 03/25/1997 | US5614394 Immunizing mice, fusion of lymphocytes and myeloma cells |